Raid at Novartis Tokyo

Share this article:

Allegations that drugmaker Novartis falsified data for its hypertension drug Diovan culminated in a police raid of its Tokyo offices Wednesday, reports the New York Times.

The country's health ministry filed a criminal complaint against Novartis in January over ads it says exaggerated the drug's impact. The Times noted Thursday that a guilty verdict could trigger a $20,000 fine and/or jail time. The Times also notes that two hospitals have stopped using the high blood pressure medication after universities retracted papers that said the drug helped prevent strokes.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.